Physician profile
Lawrence E Greiten
NPI 1104076439
$670.41
in general payments reported to CMS, 2019-2025
11 companies · $104 in 2025
The $104 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $109 · 2020: $33.37 · 2021: $35.62 · 2022: $91.19 · 2023: $144 · 2024: $153 · 2025: $104.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $401.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $401.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $193.57 | 2022-2025 | Aurora Ev-Icd Mri Surescan, Micra, Invos |
| Abbott Laboratories | $142.42 | 2019-2024 | Thoratec Heartmate 3 Lvas Implant Kit |
| Edwards Lifesciences Corporation | $99.97 | 2021-2023 | Sapien 3 Ultra Resilia |
| Elutia, INC. | $55.64 | 2019-2023 | |
| Lemaitre Vascular, INC. | $46.68 | 2019-2023 | Tyke, Patch, Pledget and Intracardiac |
| Ethicon US, LLC | $39.50 | 2025 | Dermabond, Vistaseal |
| Medtronic Vascular, INC. | $25.95 | 2019-2020 | |
| Zimmer Biomet Holdings, INC. | $22.53 | 2024 | A&E Medical / Sternalock Xp Rigid Fixation System |
| Solventum Corporation | $18.45 | 2024 | V.A.C. Veraflo Cleanse Choice, Prevena |
| Terumo Cardiovascular Systems Corporation | $16.63 | 2019 | |
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $9.07 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lawrence Greiten listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.